These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6690689)

  • 41. [Type A and B monoamine oxidase activity in hyperbaric oxygenation].
    Goroshinskaia IA
    Vopr Med Khim; 1979; 25(3):328-33. PubMed ID: 452501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs.
    Neff NH; Yang HY
    Life Sci; 1974 Jun; 14(11):2061-74. PubMed ID: 4603266
    [No Abstract]   [Full Text] [Related]  

  • 43. Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine.
    Fuller RW
    Biochem Pharmacol; 1968 Oct; 17(10):2097-106. PubMed ID: 5696879
    [No Abstract]   [Full Text] [Related]  

  • 44. [Changes induced by ethanol in monoamine oxidase activity in the rat's brain mitochondria: MAO-DA and MAO-NA].
    Renis M; Giovine A; Bertolino A
    Acta Neurol (Napoli); 1974; 29(3):293-8. PubMed ID: 4422384
    [No Abstract]   [Full Text] [Related]  

  • 45. Proceedings: Monoamine oxidase activity in distinct populations of rat brain mitochondria.
    Bourne R; Lai JC; Owen F; Crow TJ
    Br J Pharmacol; 1975 Oct; 55(2):298P. PubMed ID: 1201425
    [No Abstract]   [Full Text] [Related]  

  • 46. Kinetic studies on rat brain monoamine oxidase.
    Huszti Z
    Mol Pharmacol; 1972 Jul; 8(4):385-97. PubMed ID: 5053580
    [No Abstract]   [Full Text] [Related]  

  • 47. Molecular determinants of MAO selectivity in a series of indolylmethylamine derivatives: biological activities, 3D-QSAR/CoMFA analysis, and computational simulation of ligand recognition.
    Morón JA; Campillo M; Perez V; Unzeta M; Pardo L
    J Med Chem; 2000 May; 43(9):1684-91. PubMed ID: 10794685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deamination of dopamine and its 3-O-methylated derivative by human brain monoamine oxidase.
    Roth JA; Feor K
    Biochem Pharmacol; 1978; 27(11):1606-8. PubMed ID: 697902
    [No Abstract]   [Full Text] [Related]  

  • 49. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The heterogeneity of monoamine oxidase in distinct populations of rat brain mitochondria.
    Owen F; Bourne R
    Biochem Pharmacol; 1977 Feb; 26(4):289-92. PubMed ID: 849318
    [No Abstract]   [Full Text] [Related]  

  • 51. Multiple forms of monoamine oxidase and their properties.
    Youdim MB
    Adv Biochem Psychopharmacol; 1972; 5():67-77. PubMed ID: 4561512
    [No Abstract]   [Full Text] [Related]  

  • 52. 4-Organoseleno-Isoquinolines Selectively and Reversibly Inhibit the Cerebral Monoamine Oxidase B Activity.
    Sampaio TB; Da Rocha JT; Prigol M; Saraiva RA; Nogara PF; Stein AL; da Rocha JB; Zeni G; Nogueira CW
    J Mol Neurosci; 2016 May; 59(1):135-45. PubMed ID: 27052821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoacylcadaverines as substrates for both monoamine oxidase and diamine oxidase; low rates of activity.
    Suzuki O; Matsumoto T; Oya M; Katsumata Y; Stepita-Klauco M
    Experientia; 1980 May; 36(5):535-7. PubMed ID: 6769699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives.
    Palaska E; Aydin F; Uçar G; Erol D
    Arch Pharm (Weinheim); 2008 Apr; 341(4):209-15. PubMed ID: 18266289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Substrate specificity and inhibitor sensitivity of monoamine oxidase in rat kidney mitochondria.
    Lyles GA; Shaffer CJ
    Biochem Pharmacol; 1979 Apr; 28(7):1099-106. PubMed ID: 444267
    [No Abstract]   [Full Text] [Related]  

  • 56. Heterogeneity of pig liver and pig brain mitochondrial monoamine oxidase.
    Ekstedt B; Oreland L
    Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):157-65. PubMed ID: 984965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antioxidant Activity of Tetranitrosyl Iron Complex with Thiosulfate Ligands and Its Effect on Catalytic Activity of Mitochondrial Enzymes In vitro.
    Faingold II; Kotelnikova RA; Smolina AV; Poletaeva DA; Soldatova YV; Pokidova OV; Sadkov AP; Sanina NA; Aldoshin SM
    Dokl Biochem Biophys; 2019 Sep; 488(1):342-345. PubMed ID: 31768856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The homogeneity of pig brain mitochondrial monoamine oxidase.
    Tipton KF; Spires IP
    Biochem Pharmacol; 1968 Oct; 17(10):2137-41. PubMed ID: 5696881
    [No Abstract]   [Full Text] [Related]  

  • 60. Inhibition of a type B monoamine oxidase inhibitor, (E)-2-(4-fluorophenethyl)-3-fluoroallylamine (MDL-72974A), on semicarbazide-sensitive amine oxidases isolated from vascular tissues and sera of different species.
    Yu PH; Zuo DM
    Biochem Pharmacol; 1992 Jan; 43(2):307-12. PubMed ID: 1739419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.